Contact
Wilbert S. Aronow, M.D., has edited more than 20 books and is the author or co-author of 2,000+ papers, more than 200 chapters in 100+ books, nearly 1,000 commentaries, 50 Letters to the Editor, 1,200+ abstracts, and is a presenter or co-presenter of more than 1,600 talks at meetings. Dr. Aronow has been a member of almost 200 editorial boards of medical journals. He has been a member of 4 national guidelines committees including being a coauthor of the 2010 AMDA guidelines for heart failure, a co-chair and first author of the 2011 ACC/AHA expert consensus document on hypertension in the elderly, a coauthor of the 2015 AHA/ACC/ASH scientific statement on treatment of hypertension in patients with coronary artery disease, and a coauthor of the 2017 ACC/AHA guidelines for the management of patients with hypertension. He was a co-author of a 2015 position paper from the International Lipid Expert Forum. Dr. Aronow has been a committee member of numerous professional societies and a consultant to many government agencies. He has mentored more than 1,300 physicians and medical students and has 1,700+ papers listed on PubMed during his professional career.
Education
- Fellowship: Cardiology
- Residency: Internal Medicine
- M.D., Harvard Medical School
Areas of Expertise
- Cardiovascular Disease
- Preventive Cardiology
Honors and Awards
- 90 Honors including NYMC Chancellor's Research Award
- 2 NYMC 2021 Excellence in Teaching Dean's Faculty Award
- NYMC library 2024 Award for mentoring residents
Publications
- Vyas H, Fishkin T, Frishman WH, et. al. "Pacing for Pressure: The Clinical Efficacy of AVIM Therapy in Hypertension Management." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001382
- Tobi Y, Buffer SW, Grullon G, et. al. "Pulmonary Hypertension and Kidney Disease: A Review of a High-Risk Patient Population." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001381
- Mirhosseini SA, Sadrzadeh SA, Semirani-Nezhad D, et. al. "Baseline Ejection Fraction as a Modifier of Beta-Blocker Therapeutic Effects in Post-Acute Coronary Syndrome Patients With Non-Reduced Ejection Fraction: A Systematic Review and Meta-Analysis." Cardiovascular therapeutics, 2026(1), (2026) e2988999. doi: 10.1155/cdr/2988999
- Ramadan A, Aglan A, Salama B, et. al. "Glucagon-Like Peptide-1 Receptor Agonists in Cardiovascular Disease: Redefining Therapy Through Cardiometabolic Substrate Modification." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001322
- Furqan MS, Frishman WH, Aronow WS, et. al. "Ischemia-Modified Albumin: Review of a Novel Cardiac Biomarker and Its Clinical Applications in Cardiovascular Disease." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001369
- Gadelmawla AF, Alsubaiei AA, AlSejari NY, et. al. "Interpretable Machine Learning in Heavy Metal-Associated Cardiovascular and Metabolic Disease: A Review of Current Methodologies, Toxicological Insights, and Clinical Implications." Cardiovascular toxicology, 26(6), (2026) . pii: 64. doi: 10.1007/s12012-026-10142-7
- Eid MM, Altibi AM, Mostafa MR, et. al. "Efficacy of torsemide versus furosemide in heart failure: a systematic review and meta-analysis of randomized controlled trials." Archives of medical sciences. Atherosclerotic diseases, 11(), (2026) e45-e52. doi: 10.5114/amsad/210582
Memberships and Affiliations
- FACC
- FAHA
- FACP
- FCCP
- FASPC
- AGSF
- FGSA
Teaching Responsibilities
- Mentor cardiology fellows
- Mentor medical residents
- Mentor medical students
